Teva Pharmaceuticals
Teva Pharmaceutical to pay $519 mn to settle US bribery charges
23 December 2016
Teva Pharmaceuticals and Mylan accused of brazen price fixing
16 December 2016
Aurobindo Pharma to buy some commercial products from Teva
26 November 2016
Intas to buy Teva's UK, Ireland generics business for Rs5,083 cr
06 October 2016
Teva patent on multiple sclerosis drug invalidated
02 September 2016
Aurobindo, Intas in race for Teva's Irish generics business
29 August 2016
Mylan wins patent battle over sclerosis drug Copaxone
26 August 2016
Allergan to sell US distribution unit Anda to Teva for $500 mn
04 August 2016
US antitrust regulator approves Teva-Allergan $40.5 bn generic deal
28 July 2016
Teva to sell US generic products to Australia's Mayne Pharma for $652 mn
28 June 2016
Teva readies to divest $2 bn in assets to win US regulatory approval for Allergan
06 May 2016
European regulator approves Tevaís $40.5-bn Allergan drug unit deal with conditions
11 March 2016
Teva to buy Mexican drugmaker Rimsa for $2.3 bn
03 October 2015
IBM Watson Health, Teva Pharma tie up for Cloud solutions
12 September 2015
Teva in $40.5-bn pact to buy Allergan's generics, ends Mylan bid
27 July 2015
Teva in talks to buy Allergan's generic-drug unit for $45 bn: report
27 July 2015
Teva plans to raise bid for rival drugmaker Mylan to $42 bn
07 July 2015
Teva pressures takeover target Mylan with 1.8% stake buy
03 June 2015
Teva settles US antitrust charges for $1.2 bn
29 May 2015
Teva Pharmaceutical offers to buy Mylan NV for $40 bn
22 April 2015
Teva Pharmaceutical to buy US neurology drug firm Auspex $3.5 bn
31 March 2015
US Supreme Court turns down Teva's bid to block Mylan's generic Copaxone
19 April 2014
Ranbaxy, Teva to pay $15,000 each to settle US anti-trust case
20 February 2014
Teva Pharmaceutical to cut 5,000 jobs, save $2 bn annually
11 October 2013
Teva, Sun Pharma to pay Pfizer $2.15 bn to settle patent suit
12 June 2013
Israelís Teva, P&G tie up to set up plant in Gujarat
25 July 2012
Ranbaxy to share Lipitor profits with Teva
02 December 2011
Teva, Baxter and McKesson ordered to pay $162.5 million in damages over Propofol
11 October 2011
Teva wins US regulatory approval for $6.8-bn Cephalon acquisition
08 October 2011
Teva trumps Valeant with a $6.8-bn deal to acquire Cephalon
02 May 2011
Procter & Gamble, Teva in consumer healthcare partnership
25 March 2011
Teva to issue $750 million of bonds at Libor +0.50 per cent
17 March 2011
Teva to acquire Germany's Ratiopharm for $5 billion
18 March 2010
Teva-Kowa Pharma to acquire majority stake in Japanese genrics maker Taisho
24 December 2009
FDA bans Teva Animal Healthís veterinary drugs
03 August 2009
Sanofi settles Allegra, Nasacort patent suits with Teva, Barr
20 November 2008
Teva in bid to make generic version of Gilead's AIDS drug Truvada
15 November 2008
Dr Reddy's, Teva settle `carvedilol' patent dispute: report
12 August 2008
No1 generic drugs maker Teva acquires rival Barr Pharma for $7.46 billion
18 July 2008
Teva to acquire Bentley Pharmaceuticals
01 April 2008
US FDA grants tentative approval to Teva's generic Flomax capsules
01 February 2008
Teva to acquire CoGenesys
23 January 2008
Teva to acquire 60% stake in Sol Pharma unit
22 May 2002
 search domain-b